| Symbol | ATTBF |
|---|---|
| Name | ABATTIS BIOCEUTICALS CORP. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V6C 2T6 Canada BC Suite 1200 625 Howe Street |
| Telephone | +1 (808)-650-3007 |
| Fax | — |
| — | |
| Website | http://www.abattis.com |
| Incorporation | CA |
| Incorporated On | 1997 |
| Employees | — |
| Fiscal Year | 9/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Dale Matheson Carr-Hilton Labonte LLP; |
| Audit Status | NOT AVAILABLE |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001515768 |
| Description | Abattis is a life sciences and biotechnology company which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. The Company is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds. The Company follows strict standard operating protocols, and adheres to the applicable laws of Canada and foreign jurisdictions. Additional info from OTC: |
Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: ABATTIS BIOCEUTICALS ORD.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: ABATTIS BIOCEUTICALS ORD.
Read more